On September 10, 2025, Scinai Immunotherapeutics Ltd. entered a Standby Equity Purchase Agreement with Yorkville to sell up to $15 million of their American Depositary Shares over 36 months, with conditions and a commitment fee of $108,000. This filing is significant for investors as it outlines new financing opportunities for the company.